Fig. 4.
Natural killer group 2D (NKG2D) expression rate of NK cells in the liver cancer group.
SSC-A, side scatter (A); FSC-A, forward scatter (A); CD3 PE-Cy7-A, the CD3 antibody marked by PE-Cy7 (A); CD56 PC5-A, the CD56 antibody marked by Percp-cy5.5 (A); CD16 APC-Cy7-A, the CD16 antibody marked by APC-Cy7 (A); NKG2D FITC-A, the NKG2D antibody marked by FITC (A).